Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Douangamath

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2014
Application of in situ diffraction in high-throughput structure determination platformsPierre Aller, Juan Sanchez-Weatherby, James Foadi, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2020
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational DockingMarion Schuller, Galen J Correy, Stefan Gahbauer, et al.
Science Advances|April 15, 2021
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational dockingMarion Schuller, Galen J Correy, Stefan Gahbauer, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2014
Application of in situ diffraction in high-throughput structure determination platformsPierre Aller, Juan Sanchez-Weatherby, James Foadi, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2020
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational DockingMarion Schuller, Galen J Correy, Stefan Gahbauer, et al.
Science Advances|April 15, 2021
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational dockingMarion Schuller, Galen J Correy, Stefan Gahbauer, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 3